Cardoso Filipe S, Kok Beverley, Dong Victor, Kim Minjee, Karvellas Constantine J
Intensive Care Unit and Transplant Unit, Curry Cabral Hospital, Nova Medical School, Nova University, Lisbon, Portugal.
Liver Unit, University of Alberta, Edmonton, Alberta, Canada.
Can Liver J. 2023 Jul 26;6(2):261-268. doi: 10.3138/canlivj-2022-0037. eCollection 2023 Jul.
We applied the Confusion Assessment Method (CAM)-Intensive Care Unit (ICU)-7 delirium scale to patients who underwent liver transplant (LT).
Retrospective cohort including patients who underwent LT for cirrhosis admitted to the ICU from June 2013 to June 2016 at the University of Alberta Hospital, Canada. Delirium was assessed using the CAM-ICU-7 scale (0-7 points) twice daily on days one and 3 post LT, with the highest score being considered. Primary endpoint was hospital mortality.
Among all patients, 101/150 (67.3%) were men and mean age was 52.4 (SD 11.8) years. On days 1 and 3 post LT, mean CAM-ICU-7 scores were 1.8 (SD 1.3) and 1.6 (SD 1.8), respectively. Therefore, on days 1 and 3 post LT, 38/150 (25.3%) and 26/95 (27.4%) patients had delirium. While delirium on day 3 post LT was associated with higher hospital mortality (11.5% versus 0%; = 0.019), it was not associated with length-of-hospital stay (29.2 versus 34.4 days; = 0.36). Following adjustment for APACHEII score, delirium on day 3 post LT was associated with higher odds of hospital mortality (adjusted odds ratio [aOR] 1.89 [95% CI 1.02-3.50]). Following adjustment for Glasgow Coma Scale and mechanical ventilation, serum creatinine was associated with higher odds of delirium on day 3 post LT (aOR 2.02 [95% CI 1.08-3.77]).
Using the CAM-ICU-7 scale, delirium was diagnosed in a fourth of patients who underwent LT. Delirium on day 3 post LT was associated with higher odds of hospital mortality.
我们将意识模糊评估方法(CAM)-重症监护病房(ICU)-7谵妄量表应用于接受肝移植(LT)的患者。
回顾性队列研究纳入了2013年6月至2016年6月在加拿大阿尔伯塔大学医院重症监护病房因肝硬化接受肝移植的患者。在肝移植术后第1天和第3天,每天使用CAM-ICU-7量表(0-7分)评估谵妄两次,取最高分。主要终点是医院死亡率。
在所有患者中,101/150(67.3%)为男性,平均年龄为52.4(标准差11.8)岁。肝移植术后第1天和第3天,CAM-ICU-7量表的平均得分分别为1.8(标准差1.3)和1.6(标准差1.8)。因此,肝移植术后第1天和第3天,分别有38/150(25.3%)和26/95(27.4%)的患者发生谵妄。虽然肝移植术后第3天的谵妄与较高的医院死亡率相关(11.5%对0%;P = 0.019),但与住院时间无关(29.2天对34.4天;P = 0.36)。在对急性生理与慢性健康状况评分系统II(APACHEII)评分进行校正后,肝移植术后第3天的谵妄与较高的医院死亡几率相关(校正优势比[aOR] 1.89 [95%置信区间1.02-3.50])。在对格拉斯哥昏迷量表和机械通气进行校正后,血清肌酐与肝移植术后第3天谵妄的较高几率相关(aOR 2.02 [95%置信区间1.08-3.77])。
使用CAM-ICU-7量表,四分之一接受肝移植的患者被诊断为谵妄。肝移植术后第3天的谵妄与较高的医院死亡几率相关。